Therapeutic analysis of stereotactic radiotherapy for the treatment of metastatic hepatic carcinoma
10.3969/j.issn.1671-8348.2013.30.014
- VernacularTitle:立体定向放射治疗肝转移癌的疗效分析
- Author:
Yue WAN
;
Bing TAN
;
Yong JIANG
;
Yu BAI
;
Yongzhong WU
- Publication Type:Journal Article
- Keywords:
neoplasm metastasis;
liver neoplasms;
radiosurgery;
treatment outcome
- From:
Chongqing Medicine
2013;(30):3626-3627,3630
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical value of stereotactic radiotherapy for the treatment of metastatic hepatic carcino-ma .Methods 42 patients with metastatic hepatic carcinoma (metastases≤3 ,maximum tumor diameter≤5 cm)were treated with Co60 stereotactic radiotherapy alone .The prescription isodose of PTV was 3 .5-4 .5 Gy ,total 10 times ,the median survival time ,lo-cal control ,complication and RILD(radiation-induced liver disease) of the patients were assessed .Results The median survival date was 7 .9 months ,2 cases were complete remission ,the local control rates was 69% ,27 cases were partial remission ,and there was no serious adverse side effect ,such as severe radiation-induced hepatic injury .Conclusion The stereotactic radiotherqpy was a good choice for inoperable metastatic hepatic carcinoma .
